SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-012923
Filing Date
2017-11-13
Accepted
2017-11-13 16:59:51
Documents
57
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 877818
2 ex10-4.htm EX-10.4 281368
3 ex10-5.htm EX-10.5 32153
4 ex31-1.htm EX-31.1 17754
5 ex31-2.htm EX-31.2 18048
6 ex32-1.htm EX-32.1 7092
7 ex32-2.htm EX-32.2 7146
  Complete submission text file 0001493152-17-012923.txt   4180674

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE mrna-20170930.xml EX-101.INS 531274
9 XBRL SCHEMA FILE mrna-20170930.xsd EX-101.SCH 44489
10 XBRL CALCULATION FILE mrna-20170930_cal.xml EX-101.CAL 43945
11 XBRL DEFINITION FILE mrna-20170930_def.xml EX-101.DEF 214689
12 XBRL LABEL FILE mrna-20170930_lab.xml EX-101.LAB 323688
13 XBRL PRESENTATION FILE mrna-20170930_pre.xml EX-101.PRE 266398
Mailing Address 17870 CASTLETON STREET SUITE 250 CITY OF INDUSTRY CA 91748
Business Address 17870 CASTLETON STREET SUITE 250 CITY OF INDUSTRY CA 91748 4259083600
Marina Biotech, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-13789 | Film No.: 171196805
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1